ILIPARCIL

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C16H18O6S
Molecular Weight	338.376
Optical Activity	UNSPECIFIED
Defined Stereocenters	4 / 4
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CCC1=CC(=O)OC2=C1C=CC(O[C@@H]3SC[C@@H](O)[C@H](O)[C@H]3O)=C2

InChI

InChIKey=AJPYMAXBUCUFLQ-MSQAHXEGSA-N

InChI=1S/C16H18O6S/c1-2-8-5-13(18)22-12-6-9(3-4-10(8)12)21-16-15(20)14(19)11(17)7-23-16/h3-6,11,14-17,19-20H,2,7H2,1H3/t11-,14+,15-,16-/m1/s1

HIDE SMILES / InChI

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10461014 | https://adisinsight.springer.com/drugs/800004720

Iliparcil was developed as an orally active beta-D-xyloside venous antithrombotic agent. However, the preclinical studies of this compound were discontinued.

Approval Year

PubMed

Title	Date	PubMed
The beneficial effect of a beta-D-xyloside, Iliparcil, in the prevention of postthrombolytic rethrombosis in the rat.	1999-08-26	10461014
An improved synthesis of an umbelliferyl 5-thioxylopyranoside, precursor of the antithrombotic drug Iliparcil.	1999-05-31	10515055

Name

Type

Language

ILIPARCIL

Official Name

English

4-ETHYL-7-((5-THIO-.BETA.-D-XYLOPYRANOSYL)OXY)COUMARIN

Preferred Name

English

iliparcil [INN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C29750